Natera Inc Stock Price Increases Following Analyst Upgrades

Natera Inc, a biotechnology company, has experienced a rise in its stock price over recent days. This increase is attributed to analyst upgrades from several firms, including Royal Bank Of Canada, UBS Group, and Evercore ISI.

• The upgraded price targets from these firms have been assigned a “buy” or “strong-buy” rating.
• The positive sentiment surrounding Natera Inc has led to a significant gap up in the stock price, with shares trading at a higher level than their previous close.

As a result of the increased confidence in the company’s prospects, Natera Inc’s market value has also increased. The company’s stock price and market value will continue to be monitored for any further developments.

Key Analysts and Their Upgrades

• Royal Bank Of Canada
• UBS Group
• Evercore ISI

Price Target Changes

• The specific price target changes made by these firms have not been disclosed.